Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stratigos

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|February 25, 2026
Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: a retrospective multicenter cohort studyVasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, Maria Gerochristou, et al.
Journal of Clinical Medicine|September 27, 2025
Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective StudyIoannis-Alexios Koumprentziotis, Irene Stefanaki, Eleni Routsi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2015
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelinePhilippe Saiag, Jean-Jacques Grob, Celeste Lebbe, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness PerceptionsDimitrios Sgouros, Adamantia Milia-Argyti, Dimitrios K Arvanitis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2009
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelineClaus Garbe, Ketty Peris, Axel Hauschild, et al.
International Journal of Dermatology|January 17, 2025
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective StudyIrene Stefanaki, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, et al.
Archives of Dermatological Research|October 9, 2024
Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective studyNatalia Rompoti, Ioannis-Alexios Koumprentziotis, Irene Stefanaki, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Clinical Medicine|November 13, 2025
Management of Patients with Nickel Hypersensitivity Undergoing Patent Foramen Ovale ClosureAnastasios Apostolos, Stamatios Gregoriou, Maria Drakopoulou, et al.
Archives of Dermatological Research|April 25, 2024
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world settingNatalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|February 25, 2026
Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: a retrospective multicenter cohort studyVasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, Maria Gerochristou, et al.
Journal of Clinical Medicine|September 27, 2025
Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective StudyIoannis-Alexios Koumprentziotis, Irene Stefanaki, Eleni Routsi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2015
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelinePhilippe Saiag, Jean-Jacques Grob, Celeste Lebbe, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness PerceptionsDimitrios Sgouros, Adamantia Milia-Argyti, Dimitrios K Arvanitis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2009
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelineClaus Garbe, Ketty Peris, Axel Hauschild, et al.
International Journal of Dermatology|January 17, 2025
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective StudyIrene Stefanaki, Ioannis-Alexios Koumprentziotis, Natalia Rompoti, et al.
Archives of Dermatological Research|October 9, 2024
Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective studyNatalia Rompoti, Ioannis-Alexios Koumprentziotis, Irene Stefanaki, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Clinical Medicine|November 13, 2025
Management of Patients with Nickel Hypersensitivity Undergoing Patent Foramen Ovale ClosureAnastasios Apostolos, Stamatios Gregoriou, Maria Drakopoulou, et al.
Archives of Dermatological Research|April 25, 2024
Bimekizumab in psoriasis: a monocentric study evaluating short- and mid-term effectiveness and safety profile in a real-world settingNatalia Rompoti, Irene Stefanaki, Pantelis Panagakis, et al.
Pageof 16